Skip to content
HowShorted

Teladoc Health, Inc. short interest in 2018

In 2018, Teladoc Health, Inc.'s disclosed short interest ran from 32.89% of shares outstanding on 12 Jan 2018 to 25.59% on 31 Dec 2018, a change of -7.30 percentage points. The year's high was 34.73% on 31 Jan 2018 and its low 18.50% on 15 Oct 2018, averaging 27.63% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.78 days on 30 Apr 2018. Full history: Teladoc Health, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Teladoc Health, Inc. in 2018

2018 in figures

Start of year
32.89% (12 Jan 2018)
End of year
25.59% (31 Dec 2018)
Change
-7.30 pp
High
34.73% (31 Jan 2018)
Low
18.50% (15 Oct 2018)
Average
27.63%
Highest days to cover
30.78 (30 Apr 2018)
SEC filings marked
8

Every report in 2018

Teladoc Health, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201832.89%13.46
31 Jan 201834.73%15.92
15 Feb 201833.78%19.67
28 Feb 201833.53%16.3810-K filed, results (8-K)
15 Mar 201831.96%16.04
29 Mar 201831.90%20.25
13 Apr 201833.08%26.64
30 Apr 201828.29%30.78
15 May 201831.08%12.4410-Q filed, results (8-K)
31 May 201833.65%28.07
15 Jun 201832.85%14.17
29 Jun 201830.50%13.73
13 Jul 201829.93%17.43
31 Jul 201826.33%10.31
15 Aug 201826.12%10.1510-Q filed, results (8-K)
31 Aug 201822.36%12.82
14 Sep 201820.73%13.63
28 Sep 201819.57%9.30
15 Oct 201818.50%5.30
31 Oct 201820.07%9.22
15 Nov 201820.37%6.8610-Q filed, results (8-K)
30 Nov 201821.94%10.50
14 Dec 201823.35%7.62
31 Dec 201825.59%9.60

See also: Teladoc Health, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.